Skip to main content

BRIEF-Biogen announces Bioverativ as name of new hemophilia-focused company

* Biogen announces Bioverativ as name of new hemophilia-focused company
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.